Seattle Genetics, Pfizer To Collaborate On Tumor Drug Technology

Posted Thursday, January 06, 2011 -
Share |

Seattle Genetics, Inc., a clinical-stage biotechnology company, Thursday announced a collaboration agreement with healthcare giant Pfizer Inc. by which Pfizer will utilize Seattle Genetics' rights for antibody-drug conjugate technology with antibodies to a single oncology target. Seattle Genetics will receive an upfront fee of $8 million from Pfizer.view original article

Related News Items

Westpac - We would prefer to be sellers on rallies, retaining our EUR/USD 1.29 one month targetThursday, May 02, 2013
Westpac - "Dollar Index survived a test of important support around 81.40/50 as USD’s safe haven status came to the fore.
MetLife options active as company ups quarterly dividendTuesday, April 23, 2013
Today’s tickers: MET, ARMH & LGF MET - MetLife, Inc.
Portugal Approves 800 million Spending Cut RoundThursday, April 18, 2013
The Portuguese government approved around 800 million euros of new spending cuts on Thursday to put its EU/IMF bailout back on t
BofAML - Gold: We remove our $2,000/oz price target for 2014.Tuesday, April 16, 2013
Bank of America Merrill Lynch - "In a move last seen in 1983, gold prices collapsed by $215/oz or 14% over the last two trading
BBH - EURUSD next upside target comes in near $1.3115Sunday, April 07, 2013
Brown Brothers Harriman - "The Dollar Index is heavily weighted toward the euro, so it is not surprising that technically, the e
BBH - EURUSD The next down side target is $1.2680Monday, April 01, 2013
Brown Brothers Harriman - "Euro: March was the second consecutive month that the euro fell.
Leaprate: Cyprus final bailout agreement is worse for the FX brokersTuesday, March 26, 2013
Unlike the original proposal, uninsured depositors will likely lose around 40% (not 10%) at Cyprus' two largest banks.
Westpac - EUR/AUD 1.2350 is the next targetTuesday, March 19, 2013
Westpac - "The return of genuine political concerns in the Eurozone should continue to chip away at EUR/USD multi-week while AUD
BBH - EURUSD Risk is on the downside, where our next target is in the $1.2680-$1.27009 areaThursday, March 21, 2013
BBH - "Although our medium term outlook is for a weaker euro ($1.20 for year end), we suspect that once there is closure on Cypr

<SCRIPT language='JavaScript1.1' SRC="http://ad-emea.doubleclick.net/adj/N5826.140243.E-FOREX/B7189154.2;abr=!ie;sz=250x250;ord=0158536001369213759?"> </SCRIPT> <NOSCRIPT> <A HREF="http://ad-emea.doubleclick.net/jump/N5826.140243.E-FOREX/B7189154.2;abr=!ie4;abr=!ie5;sz=250x250;ord=0158536001369213759?"> <IMG SRC="http://ad-emea.doubleclick.net/ad/N5826.140243.E-FOREX/B7189154.2;abr=!ie4;abr=!ie5;sz=250x250;ord=0158536001369213759?" BORDER=0 WIDTH=250 HEIGHT=250 ALT="Advertisement"></A> </NOSCRIPT>